Yves Allory

15.1k citations
230 papers · 7.4k · 1 hit paper · h-index 49

Impact in

Papers in

    • Prostate Cancer Diagnosis and Treatment 56
    • Prostate Cancer Treatment and Research 26
    • Renal cell carcinoma treatment 19
    • Bladder and Urothelial Cancer Treatments 80
    • Urinary and Genital Oncology Studies 26

Yves Allory

214 papers receiving 7.2k citations

Yves Allory's Hit Papers

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses 2020 · 158 citations
1580+2+4Years since publication50100150

Peers

Yves Allory
Comparison fields: 5 of 134
  • Pulmonary and Respiratory Medicine 2.8k
  • Cancer Research 1.1k
  • Urology 335
  • Molecular Biology 2.5k
  • Oncology 888
Replace Nicolas Wernert with:
Nicolas Wernert Germany
Christopher S. Foster United Kingdom
Donna E. Hansel United States
Timothy C. Thompson United States
David Waltregny Belgium
Nam Hoon Cho South Korea
A Hittmair Austria
Bhaskar Kallakury United States
Masatoshi Eto Japan
Akiteru Goto Japan
Yves Allory relative to Nicolas Wernert Germany Nicolas Wernert's profile →
Citations per field
00.5×
Nicolas Wernert · 1×
Citations per year

Countries citing papers authored by Yves Allory

Since Specialization
Citations

This map shows the geographic impact of Yves Allory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Allory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Allory more than expected).

Fields of papers citing papers by Yves Allory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Allory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Allory. The network helps show where Yves Allory may publish in the future.

Co-authors

The 25 scholars most cited alongside Yves Allory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yves Allory Line = papers co-authored together Yves Allory links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999292
2 2010249
3 2019240
4 2010239
5 2009234
6 2006183
7 2007163
8
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
Hit paper breakdown →
2020158
9 2014138
10 2007137
11 2010124
12 2014123
13 2006118
14 2010116
15 2021110
16 200599
17 201799
18 200899
19 201297
20 201291

About Yves Allory

Yves Allory is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Cancer Research, having authored 230 papers that have together received 7.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (80 papers), Prostate Cancer Diagnosis and Treatment (56 papers), Prostate Cancer Treatment and Research (26 papers), Urinary and Genital Oncology Studies (26 papers), Renal cell carcinoma treatment (19 papers), Epigenetics and DNA Methylation (13 papers), Renal and related cancers (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.8k citations), Cancer Research (1.1k citations), Urology (335 citations), Molecular Biology (2.5k citations) and Oncology (888 citations). Yves Allory has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Alexandre de la Taille, Laurent Salomon, Dimitri Vordos, Francis Vacherot, François Radvanyi, András Hoznek, Stéphane Terry, Guillaume Ploussard, Nathalie Nicolaı̈ew and E. Minc. Their work appears in journals such as The Journal of Urology, British Journal of Urology, European Urology, World Journal of Urology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact